Intubation Tubes Market Size, Trends, Share, Growth | Report 2022-2030
The global intubation tubes market was valued at USD 2.24 billion in 2021 and it is predicted to surpass around USD 4.07 billion by 2030 with a CAGR of 6.87% from 2022 to 2030.
The global intubation tubes market demand is expected to register significant growth during the forecast period. The factors that are expected to fuel the market growth are the increasing number of people suffering from chronic disorders and rising research and development.
A healthcare professional will intubate a patient by inserting a tube into the trachea through the mouth or nose. The tube keeps the trachea open so that air may travel through it and can also be used to connect an air or oxygen delivery system. Tracheal intubation and endotracheal intubation are other terms for intubation. Intubation tubes with ventilator pumps are being utilized more frequently in surgical operations as well as to help with breathing. Elderly patients with chronic conditions like diabetes, cancer, and lung ailments frequently need intubation tubes. In addition, between 2015 and 2050, the percentage of people 60 and older in the world will nearly double, rising from 10% to over 20%. The prevalence of respiratory disorders and the necessity for surgery will both rise as the geriatric population grows. The market for intubation tubes will benefit greatly from this.
The market for intubation tubes has been severely impacted by the COVID-19 disruption of the world economy. Pandemic restrictions and necessary rules have had an impact on the supply chain for intubation tubes, which has had a direct impact on demand, production, the supply chain, and post-sale services for medical goods. However, there was a spike in demand during the pandemic, and technologies like the Critical Care Suite attempted to make intubation procedures simpler. According to GE, about 15% of Covid 19 patients needed intubation for ventilator support.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 2.24 billion |
| Revenue Forecast by 2030 | USD 4.07 billion |
| Growth rate from 2022 to 2030 | CAGR of 6.87% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Companies Covered |
Alamo Scientific, Inc., C R Bard, Inc., Cook Medical, Medtronic Plc, Olympus Corporation, Smith Medical, Sterimed Group, Teleflex Inc., and Others |
Based on the product, the market is divided into trachea intubation and gastric intubation tubes. The most common intubation tubes are those used during tracheal intubation. Due to its extensive range of applications across numerous medical procedures, the trachea intubation tube segment will have the highest share of the global intubation tube market in 2022. According to a study published in the Journal of Health and Neck Anesthesia, the most common treatment for individuals with respiratory failure is conjectured tracheal intubation with direct laryngoscopy.
The global intubation tubes market is segmented by end-user sector into hospitals, ambulatory surgical centers, and others. Hospitals, in particular, are predicted to grow at the greatest rate through 2030 owing to the higher number of procedures performed in the hospitals. The high flow of patients into the hospitals for treatment and the high number of users are patients with chronic conditions or illnesses severely are the factors to support the segment growth.
With a market share of over 39%, the North American region dominated the global market for intubation tubes in 2022. This is due to a contemporary healthcare system that is always evolving. Additionally, the incidence of chronic and respiratory disorders including cancer and asthma is rising in the region. However, over the prediction period of 2023–2030, Asia Pacific is the segment that will grow the fastest. The level of living and lifestyle patterns have significantly changed as a result of the Asia Pacific region's rapid development. Given that the region has one of the highest rates of cancer in the world, significant investments are being made in healthcare. Additionally, low-cost medical services and surgeries have further fueled the Asia-Pacific intubation tube market.
The industry is characterized by the presence of numerous significant players. The intubation tubes market is fiercely competitive, with North America and Europe controlling the majority of the world's supply. Players are adopting various strategies to compete in the market. For instance, in April 2020, Hydromer partnered with N8 Medical to become the exclusive coating supplier as well as manufacturing partner for the latter’s CeraShield™ Endotracheal Tube, which is used in the treatment of mechanically ventilated COVID-19 patients across Canada. Key global industry players include Alamo Scientific, Inc., C R Bard, Inc., Cook Medical, Medtronic Plc, Olympus Corporation, Smith Medical, Sterimed Group, Teleflex Inc., and Others.
Market Segmentation
By Product Type Outlook
By End-use Outlook
By Regional Outlook
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Intubation Tubes Market
5.1. COVID-19 Landscape: Intubation Tubes Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Intubation Tubes Market, By Product Type
8.1. Intubation Tubes Market, by Product Type, 2022-2030
8.1.1. Trechea Intubation Tubes
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Gastric
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Intubation Tubes Market, By End-use
9.1. Intubation Tubes Market, by End-use, 2022-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Intubation Tubes Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.1.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.2.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 11. Company Profiles
11.1. Alamo Scientific, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. C R Bard, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Cook Medical
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Medtronic Plc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Olympus Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Smith Medical
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Sterimed Group
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Teleflex Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Others
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers